CAS: 297-76-7; (3S,8R,9S,10R,13S,14S,17R)-17-Ethynyl-13-Methyl-2,3,6,7,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-1H-Cyclopenta[a]Phenanthrene-3,17-Diyl Diacetate

该化合物是主要用于激素避孕的合成血清化化合物,是天然激素蛋白酮的衍生物,是蛋白质和显形活动的衍生物,能够有效防止排卵,其特征是分子结构,包括一个苯乙烯基组和两个乙酸酯功能组,有助于其亲性性和稳定性;乙醇二乙酸酯一般是口服的,并已知其活动相对较少,与其他种性素相比,其诱发性活动较少,可减少与诱发性特性有关的副作用;其致癌物包括吸收,新陈代谢和排泄,半衰期可支持其用于避孕配方;此外,由于其荷尔蒙效应,可能对管理某些合成生态条件产生影响;与任何荷尔蒙药物一样,对潜在副作用和反作用的监测对于安全使用至关重要.

结构式图片

欧盟法规

C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-8017776-B2
    优先权日:2003-07-15
    标题 :Methods for synthesis of acyloxyalkyl compounds
    发明人:BHAT LAXMINARAYAN; GALLOP MARK A
    权利人:XENOPORT INC
    摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

    专利号:US-8143437-B2
    优先权日:2002-02-19
    标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
    发明人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X
    权利人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X; XENOPORT INC
    摘要:The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods for synthesizing these 1-acyl-alkyl derivatives.

    专利号:US-7667056-B2
    优先权日:2002-08-02
    标 题 :Process and new intermediates for the preparation of steroids with a progestogen activity
    发明人:GRISENTI PARIDE; PECORA FABIO; VERZA ELISA; LEONI MASSIMO; BOSSI LAURA
    权利人:POLI IND CHIMICA SPA
    摘要:The present invention relates to a new process of synthesis and to some new intermediates for the preparation of steroids with progestogen activity, more particularly, for the preparation of Desogestrel of formula (I). Said process is characterized by the regioselective reduction of the compound of formula (II) to give the intermediate of formula (III).

    专利号:US-6225298-B1
    优先权日:1994-11-22
    标 题 :Compositions and methods for contraception and for treatment of benign gynecological disorders
    发明人:SPICER DARCY V; PIKE MALCOLM CECIL; DANIELS JOHN R
    权利人:BALANCE PHARMACEUTICALS INC
    摘要:Compositions and methods for use in preventing conception or treating benign gynecological disorders, wherein an effective amount of an antiprogestational agent [e.g., progesterone (progestin, progestogen, gestagen) antagonist or progesterone synthesis inhibitor] administered over a first period of time is combined with an effective amount of a progestogen for a second period of time. The antiprogestational agent is selected from single agents or mixtures thereof. The progestogen is selected from single agents or mixtures of natural or synthetic progestogens. The formulations are effective as contraceptive agents and for treatment of benign gynecological disorders including uterine fibroids, premenstrual syndrome, dysfunctional uterine bleeding, polycystic ovarian syndrome and endometriosis.

    专利号:US-2005239725-A1
    优先权日:2002-02-19
    标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof

    专利号:US-2001016578-A1
    优先权日:1997-06-18
    标 题 :Compositions and methods for contraception and for treatment of benign gynecological disorders
    发明人:SPICER DARCY V; PIKE MALCOLM CECIL; DANIELS JOHN R
    权利人:BALANCE PHARMACEUTICALS INC
    摘要:Compositions and methods for use in preventing conception or treating benign gynecological disorders, wherein an effective amount of an antiprogestational agent [e.g., progesterone (progestin, progestogen, gestagen) antagonist or progesterone synthesis inhibitor] administered over a first period of time is combined with an effective amount of a progestogen for a second period of time. The antiprogestational agent is selected from single agents or mixtures thereof. The progestogen is selected from single agents or mixtures of natural or synthetic progestogens. The formulations are effective as contraceptive agents and for treatment of benign gynecological disorders including uterine fibroids, premenstrual syndrome, dysfunctional uterine bleeding, polycystic ovarian syndrome and endometriosis.
    湖北三晶生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sjchem.cn
    企业联系电话:0715-8618696👤
    📞湖北三晶生物科技有限公司 ⚠️参考联系方式
    联系人:尹宏
    电话:0715-8618696
    手机:13907101691
    传真:0715-8313076
    邮箱:Sanjing@hi2000.com
    通信地址: 湖北省咸宁市咸安区凤凰工业园
    邮编: 437000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省咸宁市咸安区凤凰工业园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    武汉三晶化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sjchem.cn
    电话: 027-83830687👤
    📞武汉三晶化工有限公司 ⚠️参考联系方式

    销售电话:027-83830687
    邮箱:sanjing@hi2000.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Zafar S, Yousuf S, Kayani HA, Saifullah, Khan S, Al-Majid AM, Choudhary MI. Biotransformation of oral contraceptive ethynodiol diacetate with microbial and plant cell cultures. Chem Cent J. 2012 Sep 29;6(1):109. doi: 10.1186/1752-153X-6-109.
    2: Siddique YH, Ara G, Beg T, Afzal M. Protective role of nordihydroguaiaretic acid (NDGA) against the genotoxic damage induced by ethynodiol diacetate in human lymphocytes in vitro. J Environ Biol. 2007 Apr;28(2):279-82. Hungarian. Japanese.

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
    参考文献:10.1210/jcem-29-6-807
    摘要:BECK P, WELLS SA. Comparison of the Mechanisms Underlying Carbohydrate Intolerance in Subclinical Diabetic Women During Pregnancy and During Post-partum Oral Contraceptive Steroid Treatment1. The Journal of Clinical Endocrinology & Metabolism. 1969 Jun;29(6):807–18. doi: 10.1210/jcem-29-6-807.
    参考文献:10.1016/j.arth.2007.11.009|10.1016/j.arth.2007.12.006
    摘要:Hernandez-Vaquero D, Fernandez-Carreira JM, Garcia-Sandoval MA. "A randomized clinical trial of cementless femoral stems with and without hydroxyapatite/tricalcium-phosphate coating: an 8- to 12-year follow-up study" by Yoon et al. J Arthroplasty. 2008 Apr;23(3):486–7; author reply 487. doi: 10.1016/j.arth.2007.11.009.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知